NovAliX Turns to High-Resolution Cryo-Transmission Electron Microscopy for Pre-Clinical Drug Discovery Research
Thermo Fisher Scientific’s Cryo-TEM provides critical information for small molecule and biologic drug discovery
NovAliX signs insourcing agreement with UCB Biopharma
UCB Biopharma, a Belgian biopharmaceutical company, is the latest addition to NovAliX’s growing client portfolio, which already includes five of the top 50 global pharma companies
5th NovAliX Conference: Biophysics in Drug Discovery 2018
13 June, 2018 to 15 June, 2018
NovAliX is a Contract Research Organization with chemistry and biophysical techniques. The integrated drug discovery solutions serve pharmaceutical, biotechnology companies and research institutions. Our commitment and reliability are much appreciated by a worldwide client base.